PCR Corp
St. Petersburg, Florida, 33702, United States
NCT Number: NCT04510376
Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
St. Petersburg, Florida, 33702, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects must be excluded if any of the following conditions exist:
Omeza Collagen Matrix
1.0 mg/mL Histamine Base
Aqueous Negative Control
Time frame: 20 minutes
Response of at least 3-mm diameter (with equivalent erythema) more than negative control is required as proof of presence of cutaneous allergen specific IgE
Time frame: 60 minutes
Latent reaction to skin prick (safety assessment)
Omeza, LLC
Industry
A Safety Study to Assess the Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07703982
Allergic Reaction, Hypersensitivity
Birmingham, Alabama, United States
View Trial DetailsNCT06011603
Allergic Reaction, Hypersensitivity
Chicago, Illinois, United States
View Trial DetailsNCT06957496
Allergic Reaction, Allergic Skin Reaction
Madrid, Spain
View Trial DetailsNCT06527937
Allergic Reaction, Hypersensitivity
Secaucus, New Jersey, United States
View Trial Details